Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning.

Kaltsas A, Papathanasiou K, Giannakodimos I, Zachariou A, Hoang NPC, Dung MBT, Hung TV, Chrisofos M, Sofikitis N, Dimitriadis F

Open source

DOI
10.3390/biomedicines14081821
Published
2026 Aug 13
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14081821,
  title = {Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning.},
  author = {Kaltsas A and Papathanasiou K and Giannakodimos I and Zachariou A and Hoang NPC and Dung MBT and Hung TV and Chrisofos M and Sofikitis N and Dimitriadis F},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14081821},
  url = {https://doi.org/10.3390/biomedicines14081821}
}

RIS

TY  - JOUR
TI  - Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning.
AU  - Kaltsas A
AU  - Papathanasiou K
AU  - Giannakodimos I
AU  - Zachariou A
AU  - Hoang NPC
AU  - Dung MBT
AU  - Hung TV
AU  - Chrisofos M
AU  - Sofikitis N
AU  - Dimitriadis F
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14081821
UR  - https://doi.org/10.3390/biomedicines14081821
ER  - 

APA

A, K., K, P., I, G., A, Z., NPC, H., MBT, D., TV, H., M, C., N, S., & F, D. (2026). Gemcitabine-Based Bladder Preservation in BCG-Unresponsive High-Risk NMIBC: Evidence, Limitations, and Clinical Positioning.. Biomedicines. https://doi.org/10.3390/biomedicines14081821

Source records